A new World Health Organization (WHO) report reveals that cancer treatment disparities persist globally, particularly affecting patients in low-income countries. As of this year, the report estimates that 20.6 million new cancer cases and 10 million deaths occur annually worldwide. The findings underscore significant inequities in access to cancer care, with poorer nations lagging behind their wealthier counterparts.
Cancer Cases Projected to Increase
According to the WHO, the number of cancer cases is projected to nearly double by 2050, reaching approximately 35 million. Dr. Andre Ilbawi, team lead for cancer control at the WHO, stated, "For years, the story told about cancer has been about scientific progress, new technologies, new treatment, new hope. That story is true, and it deserves to be told, but it’s not the whole story." This statement emphasizes the need for a more nuanced understanding of the cancer landscape.
In wealthier nations, survival rates for breast and childhood cancers exceed 85%, while in poorer countries, these rates drop to below 30%. This alarming disparity highlights the urgent need for improved access to cancer treatment and care in low-income regions.
Access to Cancer Drugs and Treatment
The report indicates that in low- and lower-middle-income countries, only 9% to 54% of the WHO's top-20 priority cancer drugs are available, contrasting sharply with 68% to 94% in high-income countries. Furthermore, in 23 countries, there are no radiation facilities available for cancer treatment. The lack of resources contributes to lower diagnosis rates in sub-Saharan Africa, where cancer deaths are disproportionately high.
